The global Medical Journal market size was valued at USD XXX million in 2025 and is expected to expand at a CAGR of XX% over the forecast period (2025-2033). The market growth is primarily driven by the increasing demand for medical information due to the rising prevalence of chronic diseases, technological advancements in medical research, and the growing adoption of electronic medical journals. The increasing government funding for medical research and the emergence of open access publishing are also contributing to the growth of the market. North America dominates the global medical journal market, followed by Europe and Asia Pacific. The high prevalence of chronic diseases, well-established healthcare systems, and significant research activities in North America contribute to its dominance. Europe is also a major market for medical journals, driven by the strong presence of leading medical research institutes and universities. Asia Pacific is expected to witness significant growth in the coming years due to the increasing healthcare spending and the growing adoption of electronic medical journals. Key players in the global medical journal market include The Lancet, Nature, WMA, V‧Pulse, BMJ, EMJ, NEJM Group, Chinese Medical Association, JAMA, MJA, BioMed Central, MDPI, JMIR, QJM, Via Medica, Irish Medical Journal, JKMS, and Karger.

Introduction

Global Big Data in Healthcare Market size is expected to be worth around USD 145.8 Billion by 2033 from USD 42.2 Billion in 2023, growing at a CAGR of 13.2% during the forecast period from 2024 to 2033.

Big data in healthcare encompasses vast amounts of diverse, unstructured data sourced from medical journals, biometric sensors, electronic medical records (EMRs), Internet of Medical Things (IoMT), social media platforms, payer records, omics research, and data repositories. Integrating this unstructured data into traditional systems presents considerable challenges, primarily in data structuring and standardization. Effective data structuring is essential for ensuring compatibility across systems and enabling robust analytical processes.

However, advancements in big data analytics, artificial intelligence, and machine learning have significantly enhanced the ability to convert complex healthcare data into actionable insights. These advancements have transformed healthcare, driving informed decision-making, enabling early and accurate diagnostics, facilitating precision medicine, and enhancing patient engagement through digital self-service platforms, including online portals, mobile applications, and wearable health devices.

The role of big data in pharmaceutical R&D has become increasingly central, as analytics tools streamline drug discovery, accelerate clinical trial processes, and identify potential therapeutic targets more efficiently. The demand for business intelligence solutions within healthcare is rising, fueled by the surge of unstructured data and the focus on developing tailored treatment protocols. As a result, the global market for big data in healthcare is projected to grow steadily during the forecast period.

The global medical journal market is a dynamic sector characterized by significant growth driven by several key factors. The increasing prevalence of chronic diseases, coupled with the expanding research and development activities in the pharmaceutical and biotechnology industries, fuels the demand for high-quality, peer-reviewed medical publications. Technological advancements, particularly the rise of electronic versions and online access, are transforming the way medical professionals consume information, leading to increased accessibility and broader reach. The market is segmented by application (Research Institutes, Hospitals, Individuals, Others) and type (Paper Version, Electronic Version). While the paper version segment continues to hold a market share, the electronic version demonstrates robust growth, driven by its convenience, cost-effectiveness, and widespread accessibility. Furthermore, the integration of advanced technologies like data analytics and artificial intelligence within medical journals is expected to enhance their value and functionality, further driving market expansion. Key players, including The Lancet, Nature, BMJ, and NEJM Group, are actively shaping market dynamics through innovative publishing models and strategic acquisitions. Geographical distribution reveals significant regional variations, with North America and Europe holding substantial market shares, attributed to robust healthcare infrastructure, extensive research activities, and high per capita healthcare expenditure. However, emerging economies in Asia-Pacific and other regions are exhibiting strong growth potential, driven by increasing healthcare investments and a rising middle class. The market's future trajectory reflects a consistent upward trend, with the compound annual growth rate (CAGR) projected to remain healthy for the forecast period (2025-2033). Restraints such as subscription costs and the need for open access initiatives to ensure broader access to research are prevalent. However, the continued advancement of technology, the escalating demand for evidence-based medicine, and increasing healthcare expenditures are likely to outweigh these challenges, ensuring sustainable growth. The strategic partnerships between publishers, research institutions, and healthcare providers will play a crucial role in shaping the future landscape, fostering collaboration and dissemination of crucial medical knowledge globally. This growth will likely lead to increased competition, encouraging publishers to continuously innovate and enhance the quality and accessibility of their journals.

This data accompanies the following publication:

Title: Data and systems for medication-related text classification and concept normalization from Twitter: Insights from the Social Media Mining for Health (SMM4H) 2017 shared task

Journal: Journal of the American Medical Informatics Association (JAMIA)

The evaluation data (in addition to the training data) was used for the SMM4H-2017 shared tasks, co-located with AMIA-2017 (Washington DC).

Explore the historical Whois records related to medical-journals.com (Domain). Get insights into ownership history and changes over time.

Context

Available research shows that social connections are important for our well-being. Having support from family and friends is important for our happiness and health, and is also instrumental to our ability to share information, learn from others, and seize economic opportunities.

In this dataset we can explore data on loneliness and social connections across countries and over time, and review available evidence on how and why social connections and loneliness affect our health and emotional welfare, as well as our material well-being.

Despite the fact that there is a clear link between social connections and well-being, more research is needed to understand causal mechanisms, effect sizes and changes over time.

Researches show here, oversimplified narratives that compare loneliness with smoking, or that claim we are living a ‘loneliness epidemic’, are wrong and unhelpful.

Content

Dr. Vivek Murthy, former Surgeon General of the United States, recently wrote: “Loneliness and weak social connections are associated with a reduction in lifespan similar to that caused by smoking 15 cigarettes a day”.

This ‘15 cigarettes a day’ figure has been reproduced and reported in the news many times, under headlines such as “Loneliness is as lethal as smoking 15 cigarettes per day”.

It is indeed quite a shocking comparison since around 7 million deaths globally are attributed to smoking every year, and back-of-the-envelope calculations published in medical journals say one cigarette reduces your lifespan by 11 minutes.

Here we can dig deeper to try to understand what the data and research tell us about the link between social relations and health. In a nutshell, the reading of the evidence is as follows:

• There is a huge amount of evidence showing individuals who report feelings of loneliness are more likely to have health problems later in their life.
• There is credible theory and explanation of biological mechanisms, whereby isolation can set off unconscious surveillance for social threat, producing cognitive biases, reducing sleep and affecting hormones.
• It’s very likely there is a causal link, but there is no credible experimental evidence that would allow us to have a precise estimate of the magnitude of the causal effect that loneliness has on key metrics of health, such as life expectancy.
• The fact that we struggle to pin down the magnitude of the effect of loneliness on health doesn’t mean we should dismiss the available evidence. But it does show that more research is needed.

Observational studies: A first look at the data

Measuring loneliness

Psychologists and social neuroscientists often refer to loneliness as painful isolation. The emphasis on painful is there to make a clear distinction between solitude – the state of being alone – and subjective loneliness, which is the distressing feeling that comes from unmet expectations of the types of interpersonal relationships we wish to have.

Researchers use several kinds of data to measure solitude and loneliness. The most common source of data are surveys where people are asked about different aspects of their lives, including whether they live alone, how much time they spend with other people in a given window of time (e.g. ‘last week’) or specific context (e.g. ‘at social events, clubs or places of worship’); and whether they experience feelings of loneliness (e.g. ‘I have no-one with whom I can discuss important matters with’). Researchers sometimes study these survey responses separately, but often they also aggregate them in a composite index.

Surveys confirm that people respond differently to questions about subjective loneliness and physical social isolation, which suggests people do understand these as two distinct issues.

The fact that we see such high levels of loneliness, with substantial divergence across countries, explains why this is an important and active research area. Indeed, there are literally hundreds of papers that have used survey data to explore the link between loneliness, solitude, and health. Below is an overview of what these studies find.

# # https://ourworldindata.org/uploads/2019/12/historical-one-person-households-652x550.png" alt="image100"> # # https://ourworldindata.org/uploads/2019/07/happiness-and-friends-v3-e1564090552891.png" alt="image101"> # #

Acknowledgements

https://ourworldindata.org/

Inspiration

• In this dataset we can explore data on loneliness and social connections across countries and over time, and review available evidence on how and why social connections and loneliness affect our health and emotional welfare, as well as our material well-being.

Some references

• https://population.un.org/Household/index.html#/countries/300
• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547349/

Learn more about Market Research Intellect's Medical Publishing Market Report, valued at USD 10.5 billion in 2024, and set to grow to USD 15.8 billion by 2033 with a CAGR of 5.5% (2026-2033).

International Journal of Medical Science and Clinical invention Abstract & Indexing - ResearchHelpDesk - International Journal of Medical Science and Clinical invention is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in Medical sciences, preclinical and clinical medicine, and related disciplines. The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments. International Journal of Medical Science and Clinical invention publishes articles that bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on Clinical pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications, the International Journal of Medical Science and Clinical invention also stresses the importance of Medical sciences as a rapidly and ever-expanding area of research on drug design, development, action, and evaluation contributing significantly to a variety of scientific disciplines. The journal welcomes submissions from the following disciplines: General and internal medicine, Cancer research, Genetics, Endocrinology, Gastroenterology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Pathology and Forensic Medicine, Cell and Molecular Biology, Hematology, Biochemistry, Clinical and Experimental Pathology.

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Background This bibliometric analysis examines the top 50 most-cited articles on COVID-19 complications, offering insights into the multifaceted impact of the virus. Since its emergence in Wuhan in December 2019, COVID-19 has evolved into a global health crisis, with over 770 million confirmed cases and 6.9 million deaths as of September 2023. Initially recognized as a respiratory illness causing pneumonia and ARDS, its diverse complications extend to cardiovascular, gastrointestinal, renal, hematological, neurological, endocrinological, ophthalmological, hepatobiliary, and dermatological systems. Methods Identifying the top 50 articles from a pool of 5940 in Scopus, the analysis spans November 2019 to July 2021, employing terms related to COVID-19 and complications. Rigorous review criteria excluded non-relevant studies, basic science research, and animal models. The authors independently reviewed articles, considering factors like title, citations, publication year, journal, impact factor, authors, study details, and patient demographics. Results The focus is primarily on 2020 publications (96%), with all articles being open-access. Leading journals include The Lancet, NEJM, and JAMA, with prominent contributions from Internal Medicine (46.9%) and Pulmonary Medicine (14.5%). China played a major role (34.9%), followed by France and Belgium. Clinical features were the primary study topic (68%), often utilizing retrospective designs (24%). Among 22,477 patients analyzed, 54.8% were male, with the most common age group being 26–65 years (63.2%). Complications affected 13.9% of patients, with a recovery rate of 57.8%. Conclusion Analyzing these top-cited articles offers clinicians and researchers a comprehensive, timely understanding of influential COVID-19 literature. This approach uncovers attributes contributing to high citations and provides authors with valuable insights for crafting impactful research. As a strategic tool, this analysis facilitates staying updated and making meaningful contributions to the dynamic field of COVID-19 research. Methods A bibliometric analysis of the most cited articles about COVID-19 complications was conducted in July 2021 using all journals indexed in Elsevier’s Scopus and Thomas Reuter’s Web of Science from November 1, 2019 to July 1, 2021. All journals were selected for inclusion regardless of country of origin, language, medical speciality, or electronic availability of articles or abstracts. The terms were combined as follows: (“COVID-19” OR “COVID19” OR “SARS-COV-2” OR “SARSCOV2” OR “SARS 2” OR “Novel coronavirus” OR “2019-nCov” OR “Coronavirus”) AND (“Complication” OR “Long Term Complication” OR “Post-Intensive Care Syndrome” OR “Venous Thromboembolism” OR “Acute Kidney Injury” OR “Acute Liver Injury” OR “Post COVID-19 Syndrome” OR “Acute Cardiac Injury” OR “Cardiac Arrest” OR “Stroke” OR “Embolism” OR “Septic Shock” OR “Disseminated Intravascular Coagulation” OR “Secondary Infection” OR “Blood Clots” OR “Cytokine Release Syndrome” OR “Paediatric Inflammatory Multisystem Syndrome” OR “Vaccine Induced Thrombosis with Thrombocytopenia Syndrome” OR “Aspergillosis” OR “Mucormycosis” OR “Autoimmune Thrombocytopenia Anaemia” OR “Immune Thrombocytopenia” OR “Subacute Thyroiditis” OR “Acute Respiratory Failure” OR “Acute Respiratory Distress Syndrome” OR “Pneumonia” OR “Subcutaneous Emphysema” OR “Pneumothorax” OR “Pneumomediastinum” OR “Encephalopathy” OR “Pancreatitis” OR “Chronic Fatigue” OR “Rhabdomyolysis” OR “Neurologic Complication” OR “Cardiovascular Complications” OR “Psychiatric Complication” OR “Respiratory Complication” OR “Cardiac Complication” OR “Vascular Complication” OR “Renal Complication” OR “Gastrointestinal Complication” OR “Haematological Complication” OR “Hepatobiliary Complication” OR “Musculoskeletal Complication” OR “Genitourinary Complication” OR “Otorhinolaryngology Complication” OR “Dermatological Complication” OR “Paediatric Complication” OR “Geriatric Complication” OR “Pregnancy Complication”) in the Title, Abstract or Keyword. A total of 5940 articles were accessed, of which the top 50 most cited articles about COVID-19 and Complications of COVID-19 were selected through Scopus. Each article was reviewed for its appropriateness for inclusion. The articles were independently reviewed by three researchers (JRP, MAM and TS) (Table 1). Differences in opinion with regard to article inclusion were resolved by consensus. The inclusion criteria specified articles that were focused on COVID-19 and Complications of COVID-19. Articles were excluded if they did not relate to COVID-19 and or complications of COVID-19, Basic Science Research and studies using animal models or phantoms. Review articles, Viewpoints, Guidelines, Perspectives and Meta-analysis were also excluded from the top 50 most-cited articles (Table 1). The top 50 most-cited articles were compiled in a single database and the relevant data was extracted. The database included: Article Title, Scopus Citations, Year of Publication, Journal, Journal Impact Factor, Authors, Number of Authors, Department Affiliation, Number of Institutions, Country of Origin, Study Topic, Study Design, Sample Size, Open Access, Non-Original Articles, Patient/Participants Age, Gender, Symptoms, Signs, Co-morbidities, Complications, Imaging Modalities Used and outcome.

Market Overview: The global online journal app market is experiencing steady growth, driven by increasing smartphone and internet penetration, the rising need for self-reflection and emotional well-being, and the popularity of journaling as a therapeutic practice. The market was valued at USD XXX million in 2025 and is projected to reach USD XXX million by 2033, exhibiting a CAGR of XX% from 2025 to 2033. The increasing adoption of personalized mental health apps and the growing awareness of mental health issues are further contributing to market expansion. Market Dynamics: Key trends shaping the market include the integration of artificial intelligence (AI) and machine learning (ML) to analyze journal entries and provide insights, the rise of subscription-based models offering premium features and community support, and the emergence of niche apps catering to specific interests or demographics. However, privacy concerns regarding the storage and use of personal data may restrain market growth. The market is highly competitive, with established players such as Day One, Diarium, and Penzu facing competition from emerging startups with innovative offerings. North America and Europe hold a significant market share, while Asia Pacific is projected to witness the highest growth potential due to increasing internet penetration and disposable income.

My HealtheVet (www.myhealth.va.gov) is a Personal Health Record portal designed to improve the delivery of health care services to Veterans, to promote health and wellness, and to engage Veterans as more active participants in their health care. The My HealtheVet portal enables Veterans to create and maintain a web-based PHR that provides access to patient health education information and resources, a comprehensive personal health journal, and electronic services such as online VA prescription refill requests and Secure Messaging. Veterans can visit the My HealtheVet website and self-register to create an account, although registration is not required to view the professionally-sponsored health education resources, including topics of special interest to the Veteran population. Once registered, Veterans can create a customized PHR that is accessible from any computer with Internet access.

Academic article descriptive statistics.

International Journal of Medical Science and Clinical invention Impact Factor 2024-2025 - ResearchHelpDesk - International Journal of Medical Science and Clinical invention is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in Medical sciences, preclinical and clinical medicine, and related disciplines. The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments. International Journal of Medical Science and Clinical invention publishes articles that bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on Clinical pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications, the International Journal of Medical Science and Clinical invention also stresses the importance of Medical sciences as a rapidly and ever-expanding area of research on drug design, development, action, and evaluation contributing significantly to a variety of scientific disciplines. The journal welcomes submissions from the following disciplines: General and internal medicine, Cancer research, Genetics, Endocrinology, Gastroenterology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Pathology and Forensic Medicine, Cell and Molecular Biology, Hematology, Biochemistry, Clinical and Experimental Pathology.

Journal of Investigative Dermatology Abstract & Indexing - ResearchHelpDesk - The Journal of Investigative Dermatology (JID) publishes high impact reports describing original research related to all aspects of cutaneous biology and skin disease. Descriptions of important findings that result from basic, translational, or clinical research are appropriate for submission. Clinical research can include, but is not limited to, interventional trials, genetics studies, epidemiology, and health services research. The JID places a high priority on publication of new insights into basic cutaneous biology, disease pathogenesis and treatment. Reports that describe a new methodology, technique, or tool in combination with mechanistic insights into the problem that is being investigated are encouraged. It is possible that occasional descriptions of novel technology, methodology, or resources that are of special interest or utility to JID readers could be competitive for publication, even in the absence of new mechanistic insights. Reports describing novel mutations in known genes with no new mechanistic data will not be sent for review. Case reports or case series, unless they provide new biologic insights, are rarely appropriate for the Journal. Abstracting and Indexing Biological Abstracts Current Contents - Clinical Medicine Current Contents - Life Sciences Science Citation Index Expanded Embase PubMed/Medline International Pharmaceutical Abstracts Reference Update Science Citation Index Chemical Abstracts CAB International Global Health EBSCOhost ADONIS Pascal Francis BIOSIS Citation Index Sociedad Iberoamericana de Informacion Cientifica (SIIC) Data Bases

International Journal of Medical Science and Clinical invention FAQ - ResearchHelpDesk - International Journal of Medical Science and Clinical invention is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in Medical sciences, preclinical and clinical medicine, and related disciplines. The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments. International Journal of Medical Science and Clinical invention publishes articles that bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on Clinical pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications, the International Journal of Medical Science and Clinical invention also stresses the importance of Medical sciences as a rapidly and ever-expanding area of research on drug design, development, action, and evaluation contributing significantly to a variety of scientific disciplines. The journal welcomes submissions from the following disciplines: General and internal medicine, Cancer research, Genetics, Endocrinology, Gastroenterology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Pathology and Forensic Medicine, Cell and Molecular Biology, Hematology, Biochemistry, Clinical and Experimental Pathology.

This study explores the nuances of information sharing in the context of infodemics, with a concentrated examination of the effects of opinion leaders and information attention on users’ disposition towards sharing information during public health emergencies. The research adopts a quantitative methodology, employing Structural Equation Modeling (SEM) to empirically test the proposed hypotheses. By employing a rigorous analytical framework, the research also scrutinizes the mediating role of risk perception in shaping users’ intentions to disseminate information related to public health emergencies. Additionally, it investigates the moderating effect of perceived usefulness, shedding light on how it influences the strength of the relationship between information attention and risk perception. The findings underscore the significance for public health communication strategies, emphasizing targeted messaging utilizing trusted opinion leaders and emphasizing information utility to foster responsible sharing. This research contributes to the academic conversation on infodemic management, providing empirical insights to guide policies and practices in mitigating misinformation during public health emergencies.

Advances in Medical Sciences FAQ - ResearchHelpDesk - Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines. The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments. Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever-expanding area of research on drug design, development, action, and evaluation contributing significantly to a variety of scientific disciplines. The journal welcomes submissions from the following disciplines: General and internal medicine, Cancer research, Genetics, Endocrinology, Gastroenterology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Pathology and Forensic Medicine, Cell and Molecular Biology, Hematology, Biochemistry, Clinical and Experimental Pathology. Only review articles from experts in the field will be considered for publication. The journal does not accept case reports.

Number of indicators, their categorization, and relationship to study objectives.

Advances in Medical Sciences Acceptance Rate - ResearchHelpDesk - Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines. The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments. Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever-expanding area of research on drug design, development, action, and evaluation contributing significantly to a variety of scientific disciplines. The journal welcomes submissions from the following disciplines: General and internal medicine, Cancer research, Genetics, Endocrinology, Gastroenterology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Pathology and Forensic Medicine, Cell and Molecular Biology, Hematology, Biochemistry, Clinical and Experimental Pathology. Only review articles from experts in the field will be considered for publication. The journal does not accept case reports.